PDE5 to keep them alive: The use of phosphodiesterase type-5 inhibitors in severe pulmonary hypertension associated with interstitial lung disease.
Overview publication
Title | PDE5 to keep them alive: The use of phosphodiesterase type-5 inhibitors in severe pulmonary hypertension associated with interstitial lung disease. |
Date | 2023-03-01 |
Issue name | Respirology (Carlton, Vic.) |
Issue number | v28.3:212-214 |
DOI | 10.1111/resp.14399 |
PubMed | 36318987 |
Authors | |
Keywords | interstitial lung disease, phosphodiesterase type 5 inhibitor, pulmonary fibrosis, pulmonary hypertension, sildenafil, tadalafil, treatment |
Read | Read publication |